Company
vTv Therapeutics
vTv Therapeutics has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Cadisegliatin 800 mg QD | Phase 2 | Type 1 Diabetes (T1D) |
Latest
No recent events.
Follow vTv Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.